Intracellular localization of Wilson disease protein(ATP7B), a copper-transporting ATPase.
Intracellular localization of Wilson disease protein(ATP7B), a copper-transporting ATPase.
批准号:
12670535
负责人:
HARADA Masaru
金额:
$1.34万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
威尔逊病是一种遗传性疾病,其特征是由于肝细胞胆道铜排泄缺陷导致体内铜积聚。通过在培养细胞中表达带有绿色荧光蛋白(GFP)标记的ATP7B (GFP-ATP7B),研究Wilson病基因产物ATP7B在细胞内的定位。荧光显微镜观察胞内细胞器。GFP-ATP7B与内核体晚期标记物共定位,但与高尔基体和溶酶体标记物不共定位。威尔森氏症患者有多种突变记录。患者的临床表现差异很大,但基因型-表型相关性的资料很少。我们通过表达带有GFP标记的突变体,研究了常见的ATP7B突变体His 1069Gl和突变体Asp l270Ser的分布。Asp l270Ser突变体定位于核内体晚期,而His 1069Gln突变体不定位于核内体晚期,被细胞质中的蛋白酶体降解。此外,他的1069Gl在微管组织中心形成了由降解物和中间丝组成的聚合体。在电子显微镜下,这些聚合体与Mallory小体相似。在铜耗尽和铜负载条件下,ATP7B都定位于后期核内体。ATP7B似乎将铜从细胞质转运到后期内体,铜可能通过溶酶体排泄到胆汁中。ATP7B突变引起的铜进入晚期核内体的紊乱一定是威尔森氏病的主要缺陷。ATP7B突变体的不同蛋白质特性可能部分解释了Wilson病患者的临床谱变化。
英文摘要
Wilson disease is a genetic disorder characterized by the accumulation of copper in the body due to a defect of biliary copper excretion from hepatocytes. The intracellular localization of Wilson disease gene product, ATP7B, was investigated by expressing ATP7B tagged with green fluorescent protein (GFP)(GFP-ATP7B) in cultured cells. Intracellular organelles were visualized by fluorescence microscopy. GFP-ATP7B colocalized with the late endosome markers, but not with markers for the Golgi apparatus and lysosomes. Various mutations have been documented in patients with Wilson disease. The clinical manifestations vary greatly among the patients, however, there is little information on the genotype-phenotype correlation. We investigated the distribution of a common ATP7B mutant His 1069Gl and a mutant Asp l270Ser by expressing the mutants tagged with GFP. While Asp l270Ser mutant localized in the late endosomes, His 1069Gln mutant did not locate in the late endosomes and was degraded by the proteasomes in the cytoplasm. Furthermore, His 1069Gl formed aggresomes composed of the degradates and intermediate filamentsat the microtubule-organizing center. These aggresomes were similar to Mallory bodies on electron microscopy. ATP7B localized in the late endosomes in both copper-depleting and copper-loaded conditions. ATP7B seems to translocate copper from the cytosol into the late endosomes, and copper may be excreted to bile via lysosomes. The disturbed incorporation of copper into the late endosomes caused by mutated ATP7B must be the main defect in Wilson disease. The different protein properties of ATP7B mutants may in part explain the variety of clinical spectrums in patients with Wilson disease.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
山田剛太郎: "肝と金属代謝-病態と治療をめぐる最近の知見-"肝胆膵. 41・3. 427-442 (2000)
Gotaro Yamada:“肝脏和金属代谢 - 有关病理学和治疗的最新发现”肝胆胰 41・3(2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
原田 大: "ウイルソン病蛋白(ATP7B)は肝細胞後期エンドゾームに存在する"肝サイトスケレトン研究会誌. 11. 23-25 (2001)
Dai Harada:“威尔逊病蛋白(ATP7B)存在于肝细胞的晚期内体中”肝脏细胞骨架研究学会杂志11. 23-25(2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masaru Harada et al.: "Mallory bodies, like the mutant of ATP7B seen in Wilson's disease, areaggresomes. Reply"Gastroenterology. 121. 1264-1266 (2001)
原田正等人:“马洛里小体,就像威尔逊病中看到的 ATP7B 突变体,是聚集体。回复”胃肠病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masaru Harada et al.: "A mutation of the Wilson disease protein, ATP7B, is degraded in the proteasomes and forms protein aggregates"Gastroenterology. 120. 967-974 (2001)
Masaru Harada 等人:“威尔逊病蛋白 ATP7B 的突变在蛋白酶体中被降解并形成蛋白聚集体”胃肠病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masaru Harada et al.: "Mallory bodies, like the mutant of ATP7B seen in Wilson's disease, are aggresomes. Reply"Gastroenterology. 121. 1264-1266 (2001)
原田正等人:“马洛里体,就像威尔逊病中看到的 ATP7B 突变体一样,是攻击性的。回复”胃肠病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 26 条
Role of autophagy in liver diseases associated with stress
-
批准号:23591000
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2011
-
负责人:HARADA Masaru
-
依托单位:
Mechanisms of Mallory body formation and elimination in hepatocytes
-
批准号:20590798
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:HARADA Masaru
-
依托单位:
Biological significance of the expression of a Wilson disease mutant protein
-
批准号:14570528
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2002
-
负责人:HARADA Masaru
-
依托单位:
国内基金
海外基金
“肠—肝轴”PPARα/CYP8B1胆汁酸合成信号通路在减重手术改善糖脂代谢中的作用与机制
-
批准号:82370902
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:田景琰
-
依托单位:
以胆酸为载体的肝靶向阿德福韦前体药物的研究
-
批准号:30772653
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2007
-
负责人:刘河
-
依托单位: